It is nondialysable, and studies in patients with moderate chronic kidney disease (GFR <50 ml/min/1.73 m 2) demonstrated a reduced rate of fenofibrate excretion and accumulation of the drug with ...

Patients obtaining remission of NRA in the present study have a slower rate of decline in GFR, roughly a 50% reduction in progression, compared with patients not obtaining remission (3.8 vs.